Drug-induced Parkinsonism. Clinical aspects compared with Parkinson disease

被引:12
作者
Errea-Abad, JM
Ara-Callizo, JR
Aibar-Remon, C
机构
[1] Hosp Comarcal Barbastro, Serv Neurol, E-22300 Barbastro, Huesco, Spain
[2] Hosp Miguel Servet, Serv Neurol, Zaragoza, Spain
[3] Univ Zaragoza, Dept Med Prevent & Salud Publ, Zaragoza, Spain
关键词
calcium antagonists; drug-induced Parkinsonism; Parkinson disease;
D O I
10.33588/rn.27155.98056
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Drug-induced Parkinsonism (DIP) is the second commonest cause of Parkinson syndromes, after Parkinson diseases (PD) and represents between 10% and 30% of all patients with Parkinsonism. Objectives. To study the frequency and drugs responsible for DIP and to compare some of the clinical characteristics of these patients and those with PD. patients and methods. A retrospective community based study in Bajo Aragon district to determine the frequency of PD and Society Brain Bank and DIP on the criteria of Jimenez et at. Results. Calcium antagonist were the cause of 73% of the DIP, followed by neuroleptic drugs (11.5%). There were 73% women (19/26). The patients with DIP were older than those with PD when their symptoms started (p = 0.02). In patients with DIP 48% presented with bilateral symptoms as compared with 7% in PD (p < 0.001). Conclusions. 1. Cinarizine is the main drug responsible for DIP (58%) 2. As compared with patients with PD, patients with DIP are mainly women, older, more frequently have bilateral onset of symptoms and consult the doctor sooner [Rev Neurol 1998; 27:35-9].
引用
收藏
页码:35 / 39
页数:5
相关论文
共 22 条
[11]  
Marti Masso J F, 1985, Med Clin (Barc), V85, P614
[12]  
MartiMasso JF, 1996, THERAPIE, V51, P568
[13]  
MARTIMASSO JF, 1993, ALTERACIONES NEUROLO, P87
[14]  
MENNITIIPPOLITO F, 1995, ACTA NEUROL SCAND, V92, P49
[15]  
MILLER LG, 1989, ARCH INTERN MED, V149, P2386
[16]   Drug-induced parkinsonism: Prevalence, clinical features and follow-up study in three Sicilian communities [J].
Morgante, L ;
DiRosa, AE ;
Savettieri, G ;
Reggio, A ;
Patti, F ;
Salemi, G ;
DiLorenzo, G ;
Epifanio, A ;
DiPerri, R .
JOURNAL OF NEUROLOGY, 1996, 243 (03) :293-295
[17]  
MORGANTE L, 1992, NEUROLOGY, V42, P1901
[18]  
STEPHEN PJ, 1984, LANCET, V2, P1082
[19]  
Sutcliffe RLG, 1995, ACTA NEUROL SCAND, V92, P443
[20]   STARNBERG TRIAL ON EPIDEMIOLOGY OF PARKINSONISM AND HYPERTENSION IN THE ELDERLY - PREVALENCE OF PARKINSONS-DISEASE AND RELATED DISORDERS ASSESSED BY A DOOR-TO-DOOR SURVEY OF INHABITANTS OLDER THAN 65 YEARS [J].
TRENKWALDER, C ;
SCHWARZ, J ;
GEBHARD, J ;
RULAND, D ;
TRENKWALDER, P ;
HENSE, HW ;
OERTEL, WH .
ARCHIVES OF NEUROLOGY, 1995, 52 (10) :1017-1022